• Disclaimer
• SiteMap
• Home

• about us
  • Corporate Profile
  • Board of Directors
• technology
  • GIPET®
  • Strategic Partnering
• portfolio
  • Product Pipeline
  • Strategic Partnering
  • Orazol™ (Breast Cancer)
  • Orazol™ (Bone Metastases)
  • Almerol™ (MER-103)
  • Acyline (MER-104)
  • MER-102
• investor relations
  • Corporate Profile
  • Share Information
  • Annual Reports /
    Financial Information
  • Financial Calendar
  • Investor Alert
  • Regulatory News
  • Corporate Governance
  • Analyst Coverage
  • Advisors and Registrars
  • Ownership Summary
  • Rule 26 Information
• media
• contact

Regulatory News

• Print page
• Email page

Merrion Pharmaceuticals Annual Report Year ended 31 December 2011

Merrion Pharmaceuticals plc announces the publication of its Annual Report for the financial year ended 31 December 2011 on 23 May 2012. It is available to view on the Company's website at www.merrionpharma.com.

The Company has posted the Annual Report and Accounts for the year ended 31 December 2011 to shareholders.

 

Investor Enquiries:	Media Enquiries:
Merrion Pharmaceuticals plc Jonathan O'Connell T +353 1 642 3300 www.merrionpharma.com Davy Corporate Finance Ivan Murphy T +353 1 679 6363	Slattery Communications Conor Dempsey T +353 (0)86 247 9892 E-mail: conor.dempsey@scomms.ie

 

<< Back to Regulatory News